EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pre-Exposure Prophylaxis with Vasculotide Enhances Survival and Alleviates Hematopoietic and Gastrointestinal Injury Following Lethal Total Body Irradiation

Li Wang iD, Bin Lin, Min Zhai, Lisa Hull, Asher Rothstein, Katherine S Cleveland, Hengying Ellery, Wanchang Cui iD, Mang Xiao, Juliann G Kiang iD

International Journal of Molecular Sciences · 19.02.2026 · 27 (4) · 2001

DOI: 10.3390/ijms27042001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.02.2026. Verfasst von Li Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA. Hauptthemen laut MEDLINE: Whole-Body Irradiation, Acute Radiation Syndrome, Gastrointestinal Tract, Radiation-Protective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AFRRI intramural grant, NIH/NIAID/AFRRI Interagency Agreement.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

No US Food and Drug Administration (FDA)-approved prophylaxis is currently available for Acute Radiation Syndrome (ARS), which remains a significant threat to military and civilian populations. In this study, we investigated Vasculotide (VT), a Tie2 receptor agonist mimic, as a novel pre-exposure prophylaxis designed to stabilize the vascular endothelium, one of primary targets of radiation-induced damage. To evaluate its efficacy, female B6D2F1/J mice were exposed to 9.5 Gy total body irradiation (TBI), with VT administered subcutaneously at 12 and 2 h prior to exposure. Assessments included 30-day survival, biomarkers of vascular injury, proinflammatory cytokine/chemokine profiling, and evaluation of hematopoietic (H) and gastrointestinal (GI) recovery. Our findings demonstrate that VT significantly increased 30-day survival in a dose-dependent manner, achieving a 30% survival advantage at the 20 μg/kg dose. Furthermore, VT provided robust protection against radiation-induced vascular activation and injury, effectively alleviating damage to the bone marrow (BM) and GI tract. Taken together, these results identify VT as a promising prophylactic countermeasure for ARS. By targeting the Tie2 pathway to preserve vascular integrity, VT addresses a critical gap in medical countermeasures, offering a viable strategy to enhance survival and accelerate multi-organ recovery in radiological mass-casualty scenarios.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Whole-Body IrradiationAcute Radiation SyndromeGastrointestinal TractRadiation-Protective AgentsPre-Exposure ProphylaxisRadiation Injuries, ExperimentalAnimalsFemaleMiceReceptor, TIE-2Bone MarrowCytokines

Stichwörter der Autor:innen

30-day survivalTie2 pathwayVasculotideacute radiation syndromehematopoietic and gastrointestinal recoveryproinflammatory cytokine/chemokineprophylaxistotal body irradiationvascular activation and injuryvascular endothelium

Substanzen

Receptor, TIE-2Radiation-Protective AgentsCytokines

Autor:innen und Institutionen

  • Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
  • Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA.
  • Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
  • Comparative Pathology, Department of Laboratory Animal Resources, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
  • Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
  • Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.

ORCID-Profile: Li Wang, Wanchang Cui, Juliann G Kiang

Förderung

  • AFRRI intramural grant
  • NIH/NIAID/AFRRI Interagency Agreement

Zitieren

APA

Wang, L., Lin, B., Zhai, M., Hull, L., Rothstein, A., Cleveland, K. S., Ellery, H., Cui, W., Xiao, M., & Kiang, J. G. (2026). Pre-Exposure Prophylaxis with Vasculotide Enhances Survival and Alleviates Hematopoietic and Gastrointestinal Injury Following Lethal Total Body Irradiation. International Journal of Molecular Sciences, 27(4), 2001. https://doi.org/10.3390/ijms27042001

Vancouver

Wang L, Lin B, Zhai M, Hull L, Rothstein A, Cleveland KS, et al. Pre-Exposure Prophylaxis with Vasculotide Enhances Survival and Alleviates Hematopoietic and Gastrointestinal Injury Following Lethal Total Body Irradiation. International Journal of Molecular Sciences. 2026;27(4):2001. doi:10.3390/ijms27042001

BibTeX
@article{Wang2026,
  author = {Wang, Li and Lin, Bin and Zhai, Min and Hull, Lisa and Rothstein, Asher and Cleveland, Katherine S and Ellery, Hengying and Cui, Wanchang and Xiao, Mang and Kiang, Juliann G},
  title = {Pre-Exposure Prophylaxis with Vasculotide Enhances Survival and Alleviates Hematopoietic and Gastrointestinal Injury Following Lethal Total Body Irradiation},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {4},
  pages = {2001},
  doi = {10.3390/ijms27042001}
}
Kostenlos starten →